Today, PositiveID Corp. announced that it has filed a non-provisional patent application with the U.S. Patent and Trademark Office for its iGlucose system. The technology uses wireless SMS messaging to automatically communicate a diabetic patient’s blood glucose levels from any data-capable glucose meter to an online database.
The iGlucose system, which is currently under development, is designed to communicate automatically with a wide variety of glucometers through electronics and stored information. The system will query and recognize a particular glucometer when connected to the device, one of the technology’s unique aspects due to the differences in data retrieval from different meters and manufacturers.
The iGlucose system also successfully addresses obstacles in SMS data transmission, such as 140 character limitations. To combat these issues, iGlucose employs proprietary data compression software and encryption algorithms. Further, with the iGlucose system, there is no downloading, dialing, computer, software or cell phone needed to complete the transmission.
Scott R. Silverman, Chairman and CEO of PositiveID, said, “We are pleased to file this patent application to protect the key technology underlying the iGlucose System. We believe iGlucose has the potential to revolutionize the way diabetics and their healthcare providers manage this widespread disease through more effective and consistent communication of blood sugar levels.